Furthermore, in mice models, IL-1β signaling increases hepatic lipogenesis and steatosis by upregulating fatty acid synthase, thus highlighting the link between non-alcoholic fatty liver disease and obesity [31]. The gene discussed is FASN; the disease is alcoholic fatty liver disease.